Konuma Takaaki, Ooi Jun, Takahashi Satoshi, Tomonari Akira, Tsukada Nobuhiro, Kato Seiko, Sato Aki, Monma Fumihiko, Uchimaru Kaoru, Tojo Arinobu
Department of Hematology/Oncology, Institute of Medical Science, University of Tokyo, Tokyo.
Intern Med. 2008;47(22):1987-8. doi: 10.2169/internalmedicine.47.1456. Epub 2008 Nov 17.
Acute tumor lysis syndrome (ATLS) is a well-recognized complication of systemic chemotherapy for rapidly proliferating neoplasms. ATLS has rarely occurred after intrathecal chemotherapy for the treatment of leukemia with meningeal involvement. Here, we report a case of fatal ATLS complicating intrathecal injections of methotrexate, cytarabine and hydrocortisone for acute lymphoblastic leukemia which relapsed with meningeal involvement after allogeneic stem cell transplantation. This case indicates that intrathecal chemotherapy alone may be sufficient to induce ATLS. Close monitoring and prevention of ATLS are also warranted following intrathecal chemotherapy alone.
急性肿瘤溶解综合征(ATLS)是快速增殖性肿瘤全身化疗一种公认的并发症。鞘内化疗治疗合并脑膜受累的白血病后,ATLS很少发生。在此,我们报告1例急性淋巴细胞白血病异基因干细胞移植后合并脑膜受累复发,鞘内注射甲氨蝶呤、阿糖胞苷和氢化可的松导致致命性ATLS的病例。该病例表明,单纯鞘内化疗可能足以诱发ATLS。单纯鞘内化疗后也有必要密切监测和预防ATLS。